Published in Gene Therapy Weekly, September 10th, 2009
"Thus, the unique contribution of HIF-2 alpha remains largely obscure. By using adenoviral mutant HIF-1 alpha and adenoviral mutant HIF-2 alpha constructs, where the HIFs are transcriptionally active under normoxic conditions, we show that HIF-2 alpha but not HIF-1 alpha regulates adenosine A(2A) receptor in primary...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.